同泰生物 (871354.OC)

+ 收藏

现金流量表(同泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 6,140,549.7234,831,034.8017,527,355.2444,620,418.3517,873,876.24
 收到的税费返还(元) ---5,004.296,190.24
 收到其他与经营活动有关的现金(元) -7,463,015.84882,574.542,674,797.7725,508,073.9837,290,404.40
 经营活动现金流入小计(元) -1,322,466.1235,713,609.3420,202,153.0170,133,496.6255,170,470.88
 购买商品、接受劳务支付的现金(元) 13,466,910.2231,076,358.527,894,742.8138,608,747.1314,947,825.72
 支付给职工以及为职工支付的现金(元) 1,389,984.975,609,546.063,390,380.095,954,718.453,012,237.59
 支付的各项税费(元) 1,033,080.438,420,906.183,479,076.867,122,885.352,484,522.31
 支付其他与经营活动有关的现金(元) -7,693,212.593,534,649.874,499,037.0125,399,507.6225,692,525.06
 经营活动现金流出小计(元) 8,196,763.0348,641,460.6319,263,236.7777,085,858.5546,137,110.68
 经营活动产生的现金流量净额(元) -9,519,229.15-12,927,851.29938,916.24-6,952,361.939,033,360.20
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -2,650,000.00-254,042.0013,786.00
 收到其他与投资活动有关的现金(元) -5,570,000.00-5,050,200.00-
 投资活动现金流入小计(元) -8,220,000.00-5,304,242.0013,786.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,146,196.0019,014,994.4210,387,815.8942,793,971.8726,884,935.98
 取得子公司及其他营业单位支付的现金净额(元) ---17,900,000.00-
 投资活动现金流出小计(元) 1,146,196.0019,014,994.4210,387,815.8960,693,971.8726,884,935.98
 投资活动产生的现金流量净额(元) -1,146,196.00-10,794,994.42-10,387,815.89-55,389,729.87-26,871,149.98
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---69,999,996.00-
 取得借款收到的现金(元) 7,694,000.0050,700,000.009,000,000.0044,000,000.006,000,000.00
 收到其他与筹资活动有关的现金(元) 5,000,000.007,700,000.00142,065.32--
 筹资活动现金流入小计(元) 12,694,000.0058,400,000.009,142,065.32113,999,996.006,000,000.00
 偿还债务支付的现金(元) 8,178,058.5238,000,000.089,500,000.0442,416,666.747,147,168.99
 分配股利、利润或偿付利息支付的现金(元) 1,109,636.411,649,723.161,309,234.481,705,848.451,549,151.76
 支付其他与筹资活动有关的现金(元) 4,473,019.4010,216,736.763,710,477.758,796,411.72-
 筹资活动现金流出小计(元) 13,760,714.3349,866,460.0014,519,712.2752,918,926.918,696,320.75
 筹资活动产生的现金流量净额(元) -1,066,714.338,533,540.00-5,377,646.9561,081,069.09-2,696,320.75
五、现金及现金等价物净增加额(元) -11,732,139.48-15,189,305.71-14,826,546.60-1,261,022.71-20,534,110.53
 加:期初现金及现金等价物余额(元) 11,777,677.8026,966,983.5126,966,983.5128,228,006.2228,228,006.22
 期末现金及现金等价物余额(元) 45,538.3211,777,677.8012,140,436.9126,966,983.517,693,895.69
补充资料:
 净利润(元) -3,045,861.7416,545,257.6510,651,205.6116,443,649.948,938,066.91
 固定资产和投资性房地产折旧(元) 3,450,056.348,175,120.174,174,753.407,555,614.723,468,948.76
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 3,450,056.348,175,120.174,174,753.407,555,614.723,468,948.76
 无形资产摊销(元) 1,391,314.922,638,014.811,327,385.702,604,447.60-
 长期待摊费用摊销(元) 1,326,858.603,775,054.292,258,682.573,276,422.611,530,333.01
 处置固定资产、无形资产和其他长期资产的损失(元) ---51,783.30-
 固定资产报废损失(元) -2,089.27-41,479.1841,411.68
 公允价值变动损失(元) --574.07--
 财务费用(元) 1,587,831.482,708,848.141,148,610.912,920,685.841,564,183.22
 递延所得税(元) -829,552.54-2,196,820.94-360,618.88176,413.91495,452.02
  其中:递延所得税资产减少(元) -829,552.54-2,113,480.66-360,618.88-529,534.65-310,718.02
 递延所得税负债增加(元) --83,340.28-705,948.56806,170.04
 存货的减少(元) -273,251.25-821,775.241,251,077.30-277,361.692,131,486.32
 经营性应收项目的减少(元) -28,951,515.74-44,039,624.37-4,481,261.82-15,515,740.84-39,954,443.19
 经营性应付项目的增加(元) 11,490,717.03-9,848,298.65-16,972,345.92-27,558,088.5828,657,315.43
 其他(元) 114,355.05--36,713.92--848,570.58
 现金的期末余额(元) 45,538.3211,777,677.8012,140,436.9126,966,983.517,693,895.69
 减:现金的期初余额(元) 11,777,677.8026,966,983.5126,966,983.5128,228,006.2228,228,006.22
 现金及现金等价物的净增加额(元) -11,732,139.48-15,189,305.71-14,826,546.60-1,261,022.71-20,534,110.53
公告日期 2024-08-272024-04-192023-08-252023-04-202022-08-22
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院